Promising New Cancer Vaccine

Ninety percent of all cancers share the same molecule and there are preliminary results from clinical trials that show that a vaccine developed by Vaxil Biotheraputics along with researchers at Tel Aviv University uses a small part of the molecule to stimulate the immune system to identify and destroy cancer cells and reduce levels of [...]